Skip to main content
. 2009 Dec;44(6):2079–2092. doi: 10.1111/j.1475-6773.2009.01023.x

Table 3.

Therapy Persistence for Antihypertensive, Antidepressive, and Antihyperlipidemic Therapy Classes by Study Group

Study Group
CDHP without Education (Referent) CDHP with Education
Therapy Class Persistent, n/N (%) Persistent, n/N (%) OR (95% CI) Adjusted OR* (95% CI)
Antihypertensive 415/619 (67.0) 253/356 (71.1) 1.21 (0.90–1.63) 1.18 (0.87–1.60)
Antidepressive 277/464 (59.7) 219/371 (59.0) 0.97 (0.73–1.29) 1.06 (0.79–1.42)
Antihyperlipidemic 306/399 (76.7) 177/239 (74.1) 0.87 (0.60–1.26) 0.84 (0.57–1.24)
*

Adjusted for age, sex, use of home delivery for prescription drugs in 2007, and count of maintenance medications in 2007.

CDHP, consumer-directed health plan; CI, confidence interval; OR, odds ratio.